Genetic variants in the GLP1-related genes are linked to obesity and diabetes
Figure 2: Diabetes and Incretin effect
Monitoring and titration If you are microdosing GLP-1 medications, it is important to track the side effects carefully, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
[15] GLP-1 medications facilitate weight loss primarily through reducing appetite and caloric intake and slowing gastric emptying to prolong satiety
An occasional drink won't tip the scales
Moreover, in addition to the direct action of GIP in adipose tissue to reduce serum triglyceride levels, GLP-1 may abolish the postprandial rise in triglyceride and free fatty acid concentrations by reducing intestinal absorption of dietary lipid, stemmed from the delayed gastric emptying (197, 198)